Table 2.
Survivors (n = 310) |
Nonsurvivors (n = 192) |
All patients (n = 502) | P ‐ value | |
---|---|---|---|---|
BG at admission (mmol/L) | 10.2 (7.7, 13.8) | 11.9 (9.0, 15.0) | 10.8 (8.2,14.3) | 0.002* |
MGL (mmol/L) | 10.5 ± 3.1 | 12.7 ± 2.4 | 11.6 (9.4,13.3) | <0.001* |
SD (mmol/L) | 2.6 (1.9, 3.5) | 3.9 ± 1.5 | 2.9 (2.1, 4.1) | <0.001* |
CV (%) | 25.7 (20.3, 33.3) | 30.7 ± 10.4 | 27.6 (21.2, 34.9) | <0.001* |
HbA1c (mmol/L) | 6.9 (6.1,7.9) | 7.0 (6.2, 7.8) | 6.9 (6.2,7.9) | 0.763 |
ADAG (mmol/L) | 8.4 (7.1, 10.0) | 8.6 (7.3, 9.8) | 8.4 (7.3, 10.0) | 0.784 |
GAPadm (mmol/L) | 1.8 (−0.6,4.4) | 3.3 (0.9, 6.3) | 2.3 (−0.2, 5.3) | <0.001* |
GAPmean (mmol/L) | 2.4 (−0.1, 3.5) | 4.2 (3.7, 5.0) | 3.3 (1.2, 4.2) | <0.001* |
MH, n (%) | 14 (4.5) | 45 (23.4) | 59 (11.8) | <0.001* |
SH, n (%) | 4 (1.3) | 21 (10.9) | 25 (5.0) | <0.001* |
P < 0.05. ADAG, A1C‐derived average glucose; BG, blood glucose; GAPadm, glycemic gap between blood glucose at admission and ADAG; GAPmean, glycemic gap between MGL and ADAG; MGL, mean glucose level; MH, moderate hypoglycemia, blood glucose: 2.2–3.3 mmol/L; SH, severe hypoglycemia, blood glucose:<2.2 mmol/L.